Recall Enforment Report D-0044-2015

Recall Details

Drug Recall Enforcement Report Class II voluntary initiated by Hospira Inc., originally initiated on 10-01-2014 for the product Hydromorphone Hydrochloride Injection, USP, 10 mg/mL, Rx only, packaged in a) 1 mL Single-dose Vial (NDC 0703-0110-01), packaged in 10 x 1 mL Single-dose Vials per carton (NDC 0703-0110-03); Mfd By: Hospira Inc., Lake Forest, IL 60045; Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618; and b) 1 mL Single-dose Vial, packaged in 10 x 1 mL Single-dose Vials per carton (NDC 0409-2634-01), Hospira, Inc., Lake Forest, IL 60045. The product was recalled due to lack of assurance of sterility: confirmed customer complaints of glass product container vials that may be broken or cracked.. The product was distributed nationwide and the recall is currently terminated.

Field Name Field Value
Event ID 69314 What is the Event ID?
A numerical designation assigned by FDA to a specific recall event (used for tracking purposes).
Recall Number D-0044-2015 What is the Recall Number?
An alphanumeric designation assigned by FDA to a specific, classified recalled product (used for tracking purposes).
Recall Classification Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote What is the Recall Classification?
Numerical designation (I, II, or III) that is assigned by FDA to a particular product recall that indicates the relative degree of health hazard. For recalls pending classification, the entry will display as "Not Yet Classified".
Distribution Pattern Nationwide What is the Distribution Pattern?
General area of initial distribution such as states, countries, or territories. Note that subsequent distribution by the consignees to other parties may not be included.
Product Description Hydromorphone Hydrochloride Injection, USP, 10 mg/mL, Rx only, packaged in a) 1 mL Single-dose Vial (NDC 0703-0110-01), packaged in 10 x 1 mL Single-dose Vials per carton (NDC 0703-0110-03); Mfd By: Hospira Inc., Lake Forest, IL 60045; Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618; and b) 1 mL Single-dose Vial, packaged in 10 x 1 mL Single-dose Vials per carton (NDC 0409-2634-01), Hospira, Inc., Lake Forest, IL 60045.
Reason For Recall Lack Of Assurance Of Sterility: Confirmed customer complaints of glass product container vials that may be broken or cracked. What is the Reason for Recall?
Information describing how the product is defective.
Product Quantity 145,600 vials Product Quantity
The amount of product subject to recall.
Voluntary Mandated Voluntary: Firm initiated Voluntary / Mandated
Designates that a recall was initiated voluntarily by a firm on its own volition or after being requested to recall by FDA. “Mandatory” designates that a recall was initiated under a mandatory (statutory) recall authority, a court order, or FDA order.
Report Date 10-29-2014
Recall Initiation Date 10-01-2014 What is the Recall Initiation Date?
The date that the firm first began notifying the public or their consignees of the recall.
Termination Date 03-23-2017 What is the Date Terminated?
The date that FDA terminated the recall.
Initial Firm Notification Letter Initial Firm Notification of Consignee or Public
The method(s) by which the firm initially notified the public or their consignees of a recall.
Product Type Drugs
Recalling Firm Hospira Inc.
Code Info Lot #: a) 260753F, 261403F, Exp 1FEB2015; 290153F, Exp 1MAY2015; b) 24-080-DD, Exp 1DEC2014; 25-475-DD, Exp 1JAN2015 Code Information
A list of all lot and/or serial numbers, product numbers, expiration dates, sell or use by dates, etc., which appear on the product or its labeling.
Recalled NDC Packages 0703-0110-01; 0703-0110-03; 0703-0113-01; 0703-0113-03; 0703-0018-01; 0409-2634-10; 0409-2634-01; 0409-2634-25; 0409-2634-05; 0409-2634-50
Status Terminated - A recall where FDA has determined that all reasonable efforts have been made to remove or correct the violative product in accordance with the recall strategy, and proper disposition has been made according to the degree of hazard.

Recalled Products

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0409-2634Hydromorphone Hydrochloride Hydromorphone HydrochlorideInjection, SolutionIntramuscular; Intravenous; SubcutaneousHospira, Inc.Human Prescription Drug
0703-0018Hydromorphone Hydrochloride Hydromorphone HydrochlorideInjection, SolutionIntramuscular; Intravenous; SubcutaneousTeva Parenteral Medicines, Inc.Human Prescription Drug
0703-0110Hydromorphone Hydrochloride Hydromorphone HydrochlorideInjection, SolutionIntramuscular; Intravenous; SubcutaneousTeva Parenteral Medicines, Inc.Human Prescription Drug
0703-0113Hydromorphone Hydrochloride Hydromorphone HydrochlorideInjection, SolutionIntramuscular; Intravenous; SubcutaneousTeva Parenteral Medicines, Inc.Human Prescription Drug